Stock 1167 JACOBIO PHARMACEUTICALS GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Jacobio Pharmaceuticals Group Co., Ltd.

Equities

1167

KYG4987A1094

Biotechnology & Medical Research

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:10 21/05/2024 BST 		5-day change 1st Jan Change
1.88 HKD -4.08% Intraday chart for Jacobio Pharmaceuticals Group Co., Ltd. +3.30% -48.07%
05-13 Jacobio Pharmaceuticals Reports Approval for Phase 3 Trial for Combination Therapy Between Glecirasib and Cetuximab MT
05-10 Jacobio Pharmaceuticals Group Co., Ltd. Receives Approval of Registrational Phase III Clinical Trial of Glecirasib (Jab-21822) and Epidermal Growth Factor Receptor Inhibitor Erbitux in Patients with Colorectal Cancer CI

Business Summary

Jacobio Pharmaceuticals Group Co Ltd is a China-based investment holding company mainly engaged in the research and development of new drugs at the clinical stage. The Company is primarily responsible for the independent discovery and development of innovative tumor therapies. The Company's main drug development projects include JAB-3068 and JAB-3312 clinical stage allosteric SHP2 inhibitors. The Company mainly conducts business within the domestic market.

Number of employees: 301

Sales per Business

HKD in Million2022Weight2023Weight Delta
Small-molecule Drugs
100.0 %
111 100.0 % 70 100.0 % -36.96%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
100.0 %
111 100.0 % 70 100.0 % -36.96%

Managers

Managers TitleAgeSince
Yin Xin Wang CEO
 Chief Executive Officer 59 31/05/18
Hai Jun Wang CTO
 Chief Tech/Sci/R&D Officer - -
Andrea Wang-Gillam CTO
 Chief Tech/Sci/R&D Officer 54 15/07/20
Xiaojie Wang ADM
 Chief Administrative Officer 60 30/07/18
Yun Yan Hu BRD
 Director/Board Member 61 30/07/18
Tiffany Yang HRO
 Human Resources Officer - -
Tian Zhu PRN
 Corporate Officer/Principal - -
Yuli Ding PRN
 Corporate Officer/Principal - -
Qing Xue SEC
 Corporate Secretary 36 19/08/20
Wen Lai Zhou PRN
 Corporate Officer/Principal 56 31/07/18

Members of the board

Members of the board TitleAgeSince
Rui Lin Song BRD
 Director/Board Member 61 19/08/20
Xiaojie Wang ADM
 Chief Administrative Officer 60 30/07/18
Yun Yan Hu BRD
 Director/Board Member 61 30/07/18
Te Li Chen BRD
 Director/Board Member 55 19/08/20
Ge Wu BRD
 Director/Board Member 57 19/08/20
Yin Xin Wang CEO
 Chief Executive Officer 59 31/05/18
Yan Min Tang BRD
 Director/Board Member 51 21/08/18
Wen Lai Zhou PRN
 Corporate Officer/Principal 56 31/07/18
Bai Lu BRD
 Director/Board Member 66 22/03/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 791,755,080 442,771,330 ( 55.92 %) 0 55.92 %

Shareholders

NameEquities%Valuation
Wang Yin Xiang Family
26.67 %
211,151,750 26.67 % 46 M $
CENTER LABORATORIES, INC.
11.05 %
87,486,890 11.05 % 19 M $
Hillhouse Investment Management Ltd. (Hong Kong)
5.992 %
47,443,510 5.992 % 10 M $
Bosera Asset Management Co., Ltd.
0.4179 %
3,308,400 0.4179 % 714 879 $
HSBC Jintrust Fund Management Co. Ltd.
0.2391 %
1,892,700 0.2391 % 408 975 $
Penghua Fund Management Co., Ltd.
0.1193 %
944,274 0.1193 % 204 039 $
HuaAn Fund Management Co., Ltd.
0.0774 %
612,600 0.0774 % 132 371 $
Morgan Stanley Huaxin Fund Management Co., Ltd.
0.0479 %
379,200 0.0479 % 81 938 $
Huashang Fund Management Co., Ltd.
0.0361 %
285,600 0.0361 % 61 712 $
Guotai Asset Management Co., Ltd.
0.0325 %
257,100 0.0325 % 55 554 $

Company contact information

Jacobio Pharmaceuticals Group Co., Ltd.

Building F2 No. 88, Kechuang 6th Street

101111, Beijing

+86 10 5631 5466

http://www.jacobiopharma.com
address Jacobio Pharmaceuticals Group Co., Ltd.(1167)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.818 CNY
Average target price
3.954 CNY
Spread / Average Target
+117.46%
Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
JACOBIO PHARMACEUTICALS GROUP CO., LTD. Stock Jacobio Pharmaceuticals Group Co., Ltd.
-48.07% 199M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+9.58% 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+12.41% 107B
ARGENX SE Stock argenx SE
-3.44% 21.6B
BIONTECH SE Stock BioNTech SE
-12.38% 22.31B
GENMAB A/S Stock Genmab A/S
-6.87% 19.19B
BEIGENE, LTD. Stock BeiGene, Ltd.
-3.35% 18.23B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.57% 17.62B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+7.51% 14.26B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+35.67% 12.37B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 1167 Stock
  4. Company Jacobio Pharmaceuticals Group Co., Ltd.